Total Payments
$15,890
2024 Payments
$2,391
Companies
4
Transactions
18
Medicare Patients
2,741
Medicare Billing
$186,916
Payment Breakdown by Category
Consulting$15,075 (94.9%)
Food & Beverage$815.14 (5.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $15,075 | 11 | 94.9% |
| Food and Beverage | $815.14 | 7 | 5.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| LEICA MICROSYSTEMS INC. | $15,075 | 11 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $501.29 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $185.45 | 2 | $0 (2024) |
| Travere Therapeutics, Inc. | $128.40 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,391 | 5 | LEICA MICROSYSTEMS INC. ($1,950) |
| 2023 | $2,400 | 1 | LEICA MICROSYSTEMS INC. ($2,400) |
| 2022 | $5,080 | 2 | LEICA MICROSYSTEMS INC. ($4,950) |
| 2021 | $300.00 | 1 | LEICA MICROSYSTEMS INC. ($300.00) |
| 2020 | $975.00 | 4 | LEICA MICROSYSTEMS INC. ($975.00) |
| 2019 | $4,744 | 5 | LEICA MICROSYSTEMS INC. ($4,500) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $126.86 | General |
| Category: Immunology | ||||||
| 08/09/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $58.59 | General |
| 08/08/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $128.40 | General |
| 04/27/2024 | LEICA MICROSYSTEMS INC. | — | Consulting Fee | Cash or cash equivalent | $1,950.00 | General |
| 04/17/2024 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $127.50 | General |
| 03/08/2023 | LEICA MICROSYSTEMS INC. | HydroMARK Breast Biopsy Site Marker (Device) | Consulting Fee | Cash or cash equivalent | $2,400.00 | General |
| Category: Devices | ||||||
| 08/04/2022 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $129.75 | General |
| 08/03/2022 | LEICA MICROSYSTEMS INC. | — | Consulting Fee | Cash or cash equivalent | $4,950.00 | General |
| 07/10/2021 | LEICA MICROSYSTEMS INC. | NONE (Device) | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| Category: Devices | ||||||
| 12/17/2020 | LEICA MICROSYSTEMS INC. | DIGITAL MICROSCOPES (Device) | Consulting Fee | Cash or cash equivalent | $75.00 | General |
| Category: CANCER DIAGNOSTICS | ||||||
| 12/10/2020 | LEICA MICROSYSTEMS INC. | DIGITAL MICROSCOPES (Device) | Consulting Fee | Cash or cash equivalent | $225.00 | General |
| Category: CANCER DIAGNOSTICS | ||||||
| 12/05/2020 | LEICA MICROSYSTEMS INC. | DIGITAL MICROSCOPES (Device) | Consulting Fee | Cash or cash equivalent | $150.00 | General |
| Category: CANCER DIAGNOSTICS | ||||||
| 09/28/2020 | LEICA MICROSYSTEMS INC. | DIGITAL MICROSCOPES (Device) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: CANCER DIAGNOSTICS | ||||||
| 10/14/2019 | LEICA MICROSYSTEMS INC. | DIGITAL MICROSCOPES (Device) | Consulting Fee | Cash or cash equivalent | $250.00 | General |
| Category: CANCER DIAGNOSTICS | ||||||
| 09/28/2019 | LEICA MICROSYSTEMS INC. | DIGITAL MICROSCOPES (Device) | Consulting Fee | Cash or cash equivalent | $2,750.00 | General |
| Category: CANCER DIAGNOSTICS | ||||||
| 09/12/2019 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $121.90 | General |
| 08/04/2019 | LEICA MICROSYSTEMS INC. | DIGITAL MICROSCOPES (Device) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: CANCER DIAGNOSTICS | ||||||
| 05/06/2019 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $122.14 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 580 | 1,428 | $206,728 | $35,019 |
| 2022 | 10 | 588 | 1,339 | $208,603 | $35,263 |
| 2021 | 12 | 766 | 1,861 | $343,175 | $57,539 |
| 2020 | 13 | 807 | 1,996 | $324,103 | $59,096 |
Total Patients
2,741
Total Services
6,624
Medicare Billing
$186,916
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88350 | Antibody evaluation, each additional single antibody stain procedure | Facility | 2023 | 92 | 587 | $82,180 | $14,275 | 17.4% |
| 88348 | Electron microscopy for diagnosis | Facility | 2023 | 69 | 72 | $26,640 | $4,698 | 17.6% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2023 | 109 | 347 | $22,555 | $3,520 | 15.6% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 94 | 109 | $19,426 | $3,435 | 17.7% |
| 88346 | Antibody evaluation, initial single antibody stain procedure | Facility | 2023 | 93 | 99 | $18,810 | $2,996 | 15.9% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2023 | 11 | 65 | $11,110 | $2,204 | 19.8% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2023 | 62 | 71 | $13,561 | $2,082 | 15.4% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2023 | 23 | 50 | $8,000 | $1,208 | 15.1% |
| 88365 | Genetic sequencing localization, initial procedure | Facility | 2023 | 14 | 15 | $3,900 | $552.00 | 14.2% |
| 88300 | Pathology examination of tissue using a microscope, limited examination | Facility | 2023 | 13 | 13 | $546.00 | $48.75 | 8.9% |
| 88350 | Antibody evaluation, each additional single antibody stain procedure | Facility | 2022 | 87 | 514 | $71,960 | $12,957 | 18.0% |
| 88331 | Pathology examination of specimen during surgery, first tissue block | Facility | 2022 | 26 | 85 | $29,155 | $4,531 | 15.5% |
| 88348 | Electron microscopy for diagnosis | Facility | 2022 | 66 | 66 | $24,420 | $4,392 | 18.0% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 91 | 112 | $19,040 | $3,528 | 18.5% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2022 | 102 | 301 | $19,565 | $3,117 | 15.9% |
| 88346 | Antibody evaluation, initial single antibody stain procedure | Facility | 2022 | 88 | 91 | $17,290 | $2,835 | 16.4% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2022 | 66 | 67 | $12,797 | $1,953 | 15.3% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2022 | 25 | 63 | $10,080 | $1,478 | 14.7% |
| 88365 | Genetic sequencing localization, initial procedure | Facility | 2022 | 12 | 12 | $3,120 | $376.12 | 12.1% |
| 88300 | Pathology examination of tissue using a microscope, limited examination | Facility | 2022 | 25 | 28 | $1,176 | $96.11 | 8.2% |
| 88350 | Antibody evaluation, each additional single antibody stain procedure | Facility | 2021 | 85 | 540 | $75,600 | $13,907 | 18.4% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2021 | 133 | 214 | $34,812 | $7,053 | 20.3% |
| 88348 | Electron microscopy for diagnosis | Facility | 2021 | 63 | 66 | $24,420 | $4,538 | 18.6% |
| 88360 | Microscopic genetic analysis of tumor, manual | Office | 2021 | 11 | 78 | $30,225 | $4,525 | 15.0% |
| 88331 | Pathology examination of specimen during surgery, first tissue block | Facility | 2021 | 21 | 77 | $26,411 | $4,245 | 16.1% |
About Jonathan Zuckerman, MD, PHD
Jonathan Zuckerman, MD, PHD is a Anatomic Pathology healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/28/2014. The National Provider Identifier (NPI) number assigned to this provider is 1205246337.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jonathan Zuckerman, MD, PHD has received a total of $15,890 in payments from pharmaceutical and medical device companies, with $2,391 received in 2024. These payments were reported across 18 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($15,075).
As a Medicare-enrolled provider, Zuckerman has provided services to 2,741 Medicare beneficiaries, totaling 6,624 services with total Medicare billing of $186,916. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Anatomic Pathology
- Location Los Angeles, CA
- Active Since 04/28/2014
- Last Updated 04/28/2014
- Taxonomy Code 207ZP0101X
- Entity Type Individual
- NPI Number 1205246337
Products in Payments
- DIGITAL MICROSCOPES (Device) $5,475
- HydroMARK Breast Biopsy Site Marker (Device) $2,400
- NONE (Device) $300.00
- Fabhalta (Drug) $126.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology Doctors in Los Angeles
Peter Tontonoz, Md, MD
Anatomic Pathology — Payments: $13.6M
Anatomic Pathology $13.6M
Sheeja Pullarkat, Md, MD
Anatomic Pathology — Payments: $213,828
Anatomic Pathology $213,828
Michael Press, Md, MD
Anatomic Pathology — Payments: $98,333
Anatomic Pathology $98,333
Anthony Sisk, Do, DO
Anatomic Pathology — Payments: $82,608
Anatomic Pathology $82,608
Scott Nelson, Md, MD
Anatomic Pathology — Payments: $80,500
Anatomic Pathology $80,500
Dinesh Rao, Md, MD
Anatomic Pathology — Payments: $51,417
Anatomic Pathology $51,417